Cian Healthcare Limited (BOM:542678)
India · Delayed Price · Currency is INR 100.18
+1.80 (1.83%)
At close: Jan 20, 2026
Cian Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 232.25 | 307.98 | 616.96 | 685.9 | 778.7 | 737.3 | Upgrade |
Other Revenue | 0.55 | 0.55 | 1.96 | 0.86 | 1.95 | 2.1 | Upgrade |
| 232.8 | 308.54 | 618.92 | 686.76 | 780.66 | 739.41 | Upgrade | |
Revenue Growth (YoY) | -51.68% | -50.15% | -9.88% | -12.03% | 5.58% | 28.98% | Upgrade |
Cost of Revenue | 215.75 | 230.18 | 313.51 | 340.88 | 486.5 | 408.95 | Upgrade |
Gross Profit | 17.05 | 78.36 | 305.4 | 345.88 | 294.16 | 330.46 | Upgrade |
Selling, General & Admin | 56.52 | 74.77 | 97.76 | 101.31 | 104.48 | 77.63 | Upgrade |
Other Operating Expenses | 50.62 | 68.85 | 94.99 | 113.81 | 144.06 | 130.84 | Upgrade |
Operating Expenses | 146.28 | 187.54 | 247.41 | 269.43 | 291.29 | 243 | Upgrade |
Operating Income | -129.23 | -109.18 | 57.99 | 76.45 | 2.86 | 87.46 | Upgrade |
Interest Expense | -2.26 | -26.27 | -55.86 | -57.83 | -61.64 | -75.44 | Upgrade |
Interest & Investment Income | 1.51 | 1.51 | 1.04 | 1.41 | 1.61 | 1.93 | Upgrade |
Currency Exchange Gain (Loss) | 0.57 | 0.57 | 1.4 | 3.75 | 1.68 | -1.25 | Upgrade |
Other Non Operating Income (Expenses) | 1.54 | -4.05 | -4.09 | -5.02 | -3.8 | -3.73 | Upgrade |
EBT Excluding Unusual Items | -127.86 | -137.42 | 0.48 | 18.77 | -59.3 | 8.97 | Upgrade |
Other Unusual Items | -2.07 | -122.54 | 0.04 | 1.14 | -0.73 | -2.1 | Upgrade |
Pretax Income | -129.93 | -259.95 | 0.52 | 19.91 | -60.03 | 6.87 | Upgrade |
Income Tax Expense | 0.56 | -0.18 | -7.97 | -0.39 | -4.7 | 6.34 | Upgrade |
Net Income | -130.49 | -259.78 | 8.49 | 20.3 | -55.34 | 0.53 | Upgrade |
Net Income to Common | -130.49 | -259.78 | 8.49 | 20.3 | -55.34 | 0.53 | Upgrade |
Net Income Growth | - | - | -58.19% | - | - | - | Upgrade |
Shares Outstanding (Basic) | 25 | 25 | 25 | 25 | 25 | 27 | Upgrade |
Shares Outstanding (Diluted) | 25 | 25 | 25 | 25 | 25 | 27 | Upgrade |
Shares Change (YoY) | -0.04% | - | 0.00% | - | -5.85% | 13.65% | Upgrade |
EPS (Basic) | -5.22 | -10.39 | 0.34 | 0.81 | -2.21 | 0.02 | Upgrade |
EPS (Diluted) | -5.22 | -10.39 | 0.34 | 0.81 | -2.21 | 0.02 | Upgrade |
EPS Growth | - | - | -58.09% | - | - | - | Upgrade |
Free Cash Flow | 89.19 | 203.46 | 107.85 | 35.16 | -87.4 | 44.62 | Upgrade |
Free Cash Flow Per Share | 3.57 | 8.14 | 4.32 | 1.41 | -3.50 | 1.68 | Upgrade |
Gross Margin | 7.32% | 25.40% | 49.34% | 50.36% | 37.68% | 44.69% | Upgrade |
Operating Margin | -55.51% | -35.39% | 9.37% | 11.13% | 0.37% | 11.83% | Upgrade |
Profit Margin | -56.05% | -84.20% | 1.37% | 2.96% | -7.09% | 0.07% | Upgrade |
Free Cash Flow Margin | 38.31% | 65.94% | 17.43% | 5.12% | -11.20% | 6.03% | Upgrade |
EBITDA | -90.09 | -65.27 | 112.66 | 130.76 | 45.61 | 121.99 | Upgrade |
EBITDA Margin | -38.70% | -21.15% | 18.20% | 19.04% | 5.84% | 16.50% | Upgrade |
D&A For EBITDA | 39.14 | 43.91 | 54.67 | 54.31 | 42.75 | 34.53 | Upgrade |
EBIT | -129.23 | -109.18 | 57.99 | 76.45 | 2.86 | 87.46 | Upgrade |
EBIT Margin | -55.51% | -35.39% | 9.37% | 11.13% | 0.37% | 11.83% | Upgrade |
Effective Tax Rate | - | - | - | - | - | 92.27% | Upgrade |
Revenue as Reported | 240.52 | 310.67 | 621.36 | 692.08 | 784.07 | 740.11 | Upgrade |
Advertising Expenses | - | 0.48 | 8.53 | 2.26 | 1.78 | 2.74 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.